Mehul H. Doshi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Mehul H. Doshi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Ashwin Mahendra
Department of Interventional Oncology, Miami Cancer Institute, Baptist Health South Florida, Miami, Florida
1 shared publication - Dania Daye
Division of Interventional Radiology, Department of Radiology, Massachusetts General Hospital
1 shared publication - Govindarajan Narayanan
Florida International University
1 shared publication - Nicole M. Wilson
Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA
1 shared publication - Raihan Noman
Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA
1 shared publication
Latest Publications
- Open Access
Ablation in Pancreatic Cancer: Past, Present and Future
The insidious onset and aggressive nature of pancreatic cancer contributes to the poor treatment response and high mortality of this devastating disease. While surgery, chemotherapy and radiation have contributed to improvements in overall survival, roughly 90% of those afflicted by this disease will die within 5 years of diagnosis. The developed ablative locoregional treatment modalities have demonstrated promise in terms of overall survival and quality of life. In this review, we discuss some of the recent studies demonstrating the safety and efficacy of ablative treatments in patients with locally advanced pancreatic cancer.
Open AccessAblation in Pancreatic Cancer: Past, Present and Future
The insidious onset and aggressive nature of pancreatic cancer contributes to the poor treatment response and high mortality of this devastating disease. While surgery, chemotherapy and radiation have contributed to improvements in overall survival, roughly 90% of those afflicted by this disease will die within 5 years of diagnosis. The developed ablative locoregional treatment modalities have demonstrated promise in terms of overall survival and quality of life. In this review, we discuss some of the recent studies demonstrating the safety and efficacy of ablative treatments in patients with locally advanced pancreatic cancer.